Koers Kazia Therapeutics Ltd Australian S.E.
Aandelen
NRT
AU0000NRTDA2
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 10K 6,65K 6,13K | Omzet 2023 | 555 369,19 340,33 | Marktkapitalisatie | 39,72 mln. 26,42 mln. 24,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -24 mln. -15,96 mln. -14,72 mln. | Nettowinst (verlies) 2023 | -20 mln. -13,3 mln. -12,26 mln. | EV/omzet 2022 | 7.714 x |
Nettoliquiditeiten 2022 | 7,36 mln. 4,9 mln. 4,51 mln. | Nettoliquiditeiten 2023 | 3,44 mln. 2,29 mln. 2,11 mln. | EV/omzet 2023 | 65.355 x |
K/w-verhouding 2022 |
-3,27
x | K/w-verhouding 2023 |
-1,55
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,6% |
Recentste transcriptie over Kazia Therapeutics Ltd
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |